General MedicationsINJECTIONStandard
CAVERJECT IMPULSE
ALPROSTADIL
Standard Dose
0.01MG/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview CAVERJECT IMPULSE is listed in Drugs@FDA under application 021212 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient ALPROSTADIL Form and strength INJECTABLE;INJECTION - 0.01MG/VIAL Sponsor PFIZER Submission history Latest submission status date: 2022-12-23 00:00:00.
Structured Monograph
Clinical summary
Approval overview CAVERJECT IMPULSE is listed in Drugs@FDA under application 021212 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ALPROSTADIL Form and strength INJECTABLE;INJECTION - 0.01MG/VIAL Sponsor PFIZER Submission history Latest submission status date: 2022-12-23 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.